Bicara Therapeutics Inc.
SEC 4 · Filed
0001628280-25-059035Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Dec 26, 2025
Exercise or conversion by Raben David
- Security
- Stock Option (Right to Buy)
- Shares
-
19,789
- Price per share
-
0.00
Structured facts
{
"code": "M",
"date": "2025-12-26",
"direction": "D",
"exercise_price": "3.7898",
"expiration": "2033-08-08",
"footnotes": {
"F2": "25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person\u0027s continued service on each such vesting date."
},
"owners": [
{
"cik": "0002034679",
"name": "Raben David",
"roles": [
"officer"
],
"title": "Chief Medical Officer"
}
],
"ownership": "D",
"post_shares": "98987",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Stock Option (Right to Buy)",
"shares": "19789",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "19789"
}Insider transactionsEvent date Dec 26, 2025
Exercise or conversion by Raben David
- Security
- Common Stock
- Shares
-
19,789
- Price per share
-
3.79
Reported 3.7898
Structured facts
{
"code": "M",
"date": "2025-12-26",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "This is an ISO exercise and hold to acquire and retain direct share ownership of the issuer."
},
"owners": [
{
"cik": "0002034679",
"name": "Raben David",
"roles": [
"officer"
],
"title": "Chief Medical Officer"
}
],
"ownership": "D",
"post_shares": "55286",
"price": "3.7898",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "19789",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}